Epicorynoxidine

CAS No. 58000-48-9

Epicorynoxidine( —— )

Catalog No. M29137 CAS No. 58000-48-9

Epicorynoxidine is an alkaloid derived from the herbs of Corydalis tashiroi.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 447 Get Quote
5MG 773 Get Quote
10MG 1031 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Epicorynoxidine
  • Note
    Research use only, not for human use.
  • Brief Description
    Epicorynoxidine is an alkaloid derived from the herbs of Corydalis tashiroi.
  • Description
    Epicorynoxidine is an alkaloid derived from the herbs of Corydalis tashiroi.(In Vitro):Epicorynoxidine shows cytotoxicity of P-388 cell lines with ED50 of 25.53 μg/mL.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    58000-48-9
  • Formula Weight
    371.433
  • Molecular Formula
    C21H25NO5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COc1cc2CC[N@+]3([O-])Cc4c(C[C@H]3c2cc1OC)ccc(OC)c4OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • EGCG Octaacetate

    EGCG Octaacetate a prodrug of EGCG is utilized to enhance the stability and bioavailability of EGCG in vivo. It has high efficacy bioavailability anti-oxidation and anti-angiogenesis capacities.

  • Tamarixetin

    Tamarixetin (4'-O-Methyl Quercetin) is a natural flavonoid derivative of quercetin, with anti-oxidative and anti-inflammatory effects. Tamarixetin protects against cardiac hypertrophy.

  • Frovocimab

    Frovocimab (LY 3015014) is a humanized IgG4 monoclonal antibody to Subtilisin/Kexin Protein Converting Enzyme Type 9 (PCSK9) that binds to the catalytic domain of PCSK9 and lowers low-density lipoprotein cholesterol (LDL-C) in patients with hypercholesterolemia.Frovocimab is used in the study of hypercholesterolemia.